Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,690.00
Bid: 8,688.00
Ask: 8,692.00
Change: -8.00 (-0.09%)
Spread: 4.00 (0.05%)
Open: 8,832.00
High: 8,990.00
Low: 8,682.00
Yest. Close: 8,698.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

TOP NEWS: Astra Reports Positive Trial Results For Two Cancer Drugs

TOP NEWS: Astra Reports Positive Trial Results For Two Cancer Drugs

29 May 20 15:06

LONDON MARKET MIDDAY: Stocks Fall Ahead Of Trump Press Conference

LONDON MARKET MIDDAY: Stocks Fall Ahead Of Trump Press Conference

29 May 20 12:19

UK WINNERS & LOSERS SUMMARY: Astra Rises On Positive Trial Results

UK WINNERS & LOSERS SUMMARY: Astra Rises On Positive Trial Results

29 May 20 10:59

LONDON MARKET OPEN: Stocks Start Lower Ahead Of Trump Press Conference

LONDON MARKET OPEN: Stocks Start Lower Ahead Of Trump Press Conference

29 May 20 08:51

AstraZeneca upbeat on latest 'Tagrisso' trial results

(Sharecast News) - AstraZeneca said on Friday that detailed results from the phase 3 'ADAURA' trial showed that 'Tagrisso', or osimertinib, demonstrated a "statistically significant and clinically meaningful improvement" in disease-free survival in the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), after complete tumour resection with curative intent.

29 May 20 07:34

TOP NEWS: Strong Results From AstraZeneca's Tagrisso Lung Cancer Trial

TOP NEWS: Strong Results From AstraZeneca's Tagrisso Lung Cancer Trial

29 May 20 07:00

Initial results of study into Oxford's Covid-19 vaccine imminent, AstraZeneca chief says

(Sharecast News) - Some members of the Oxford University research team trying to develop a vaccine against the novel corona virus are already privy to initial results for early-stage human trials and their publication is imminent, AstraZeneca's chief said.

28 May 20 18:19

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

28 May 20 12:41

Merck to pursue Covid-19 vaccine using same approach as against Ebola

(Sharecast News) - US pharmaceutical giant Merck has penned an agreement with researchers at IAVI to develop a vaccine candidate against the novel coronavirus which provokes Covid-19 using the same underlying technology as the ERVEBO vaccine for the Ebola virus.

26 May 20 12:33

Sanofi to sell stake in Covid-19 treatment maker Regeneron

(Sharecast News) - Sanofi will sell its stake in US-based maker of Covid-19 treatments Regeneron Pharmaceuticals.

26 May 20 11:59

Oxford University's push for Covid-19 vaccine may stumble due to drop in infections

(Sharecast News) - Oxford University's attempts to develop a vaccine against the novel coronavirus could run into an apparently unexpected hurdle, the head of its research team said.

26 May 20 11:53

Novavax begins trialling Covid-19 vaccine in Australia

(Sharecast News) - Biotechnology firm Novavax has begun trialling a Covid-19 vaccine candidate in Australia as it hopes to release a proven vaccine by the end of 2020.

26 May 20 11:11

AstraZeneca And ArcherDX Team Up For Imfinzi Lung Cancer Trial

AstraZeneca And ArcherDX Team Up For Imfinzi Lung Cancer Trial

26 May 20 10:53

Fauci predicts US could have vaccine by end of 2020

(Sharecast News) - Top White House health expert Anthony Fauci is confident that the US could begin to roll out a coronavirus vaccine by December.

22 May 20 15:16

Fauci predicts US could have vaccine by end of 2020

(Sharecast News) - Top White House health expert Anthony Fauci is confident that the US could begin to roll out a coronavirus vaccine by December.

22 May 20 15:16

Login to your account

Don't have an account? Click here to register.